Evidence map›Paper›PMID 33576010›Full record

ArticleActa obstetricia et gynecologica Scandinavica2021

Evaluation of repeat testing of a non-sequencing based NIPT test on a Finnish general-risk population.

Filip Karlsson, Tarja Ahola, Jenny Dahlberg, Lawrence Prensky, Helena Moilanen, Heli Spalding

Abstract readEvaluation Study
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Filip KarlssonPerkinElmer Inc., Vanadis Diagnostics, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-0860-1500
Tarja AholaPerkinElmer Inc., Vanadis Diagnostics, Stockholm, Sweden.
Jenny DahlbergPerkinElmer Inc., Vanadis Diagnostics, Stockholm, Sweden.
Lawrence PrenskyPerkinElmer Inc., Waltham, MA, USA.ORCID https://orcid.org/0000-0003-4427-9122
Helena MoilanenNordlab, Oulu, Finland.
Heli SpaldingObstetrics and Gynecology, Terveystalo Healthcare Services, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo evaluate the effect of repeating test failures using an automated, non-sequencing based non-invasive prenatal testing test on a general-risk population in Finland. MATERIAL AND

methodsA total of 545 samples from women who represent the average-risk population in Oulu, Finland were analyzed with Vanadis

resultsThere were eight test failures after first-pass analysis, representing 1.5% of samples (95% CI 0.6%-2.9%). Seven out of eight failures could be resolved by analysis of a second sample, thereby reducing the test failure rate from 1.5% to 0.2% (95% CI 0.0%-1.0%).

conclusionsRepeating test failures with a second plasma sample could significantly reduce the effective failure rate, thereby providing a way to effectively minimize test failures and further improving clinical utility and test performance.

Indexed as

Genetic TestingPrenatal DiagnosisAdultDiagnostic ErrorsFemaleFinlandHigh-Throughput Nucleotide SequencingHumansPregnancyTrisomy 13 SyndromeTrisomy 18 SyndromeYoung Adultcell-free DNAnon-invasive prenatal screeningnon-invasive prenatal testingprenatal screeningprenatal testingtest failureVanadis

Identifiers

PMID33576010
PMCPMC8362176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.